AAAAAA
Results:
1-11
|
Results: 11
Authors:
Tur, MK
Sasse, S
Stocker, M
Djabelkhir, K
Huhn, M
Matthey, B
Gottstein, C
Pfitzner, T
Engert, A
Barth, S
Citation: Mk. Tur et al., An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines, INT J MOL M, 8(5), 2001, pp. 579-584
Authors:
Pahud, D
Matthey, B
Citation: D. Pahud et B. Matthey, Comparison of the thermal performance of double U-pipe borehole heat exchangers measured in situ, ENERG BLDG, 33(5), 2001, pp. 503-507
Authors:
Sundarapandiyan, K
Keler, T
Behnke, D
Engert, A
Barth, S
Matthey, B
Deo, YM
Graziano, RF
Citation: K. Sundarapandiyan et al., Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells, J IMMUNOL M, 248(1-2), 2001, pp. 113-123
Authors:
Matthey, B
Engert, A
Barth, S
Citation: B. Matthey et al., Recombinant immunotoxins for the treatment of Hodgkin's disease (Review), INT J MOL M, 6(5), 2000, pp. 509-514
Authors:
Barth, S
Huhn, M
Matthey, B
Klimka, A
Galinski, EA
Engert, A
Citation: S. Barth et al., Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions, APPL ENVIR, 66(4), 2000, pp. 1572-1579
Authors:
Barth, S
Huhn, M
Matthey, B
Schnell, R
Tawadros, S
Schinkothe, T
Lorenzen, J
Diehl, V
Engert, A
Citation: S. Barth et al., Recombinant anti-CD25 immunotoxin RFT5(scFv)-ETA ' demonstrates successfulelimination of disseminated human Hodgkin lymphoma in SCID mice, INT J CANC, 86(5), 2000, pp. 718-724
Authors:
Klimka, A
Matthey, B
Roovers, RC
Barth, S
Arends, JW
Engert, A
Hoogenboom, HR
Citation: A. Klimka et al., Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning, BR J CANC, 83(2), 2000, pp. 252-260
Authors:
Barth, S
Huhn, M
Matthey, B
Tawadros, S
Schnell, R
Schinkothe, T
Diehl, V
Engert, A
Citation: S. Barth et al., Ki-4(scFv)-ETA ', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice, BLOOD, 95(12), 2000, pp. 3909-3914
Authors:
Barth, S
Matthey, B
Huhn, M
Diehl, V
Engert, A
Citation: S. Barth et al., Cl430L-ETA ': A new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma, CYTOK CELL, 5(2), 1999, pp. 69-77
Authors:
Matthey, B
Engert, A
Klimka, A
Diehl, V
Barth, S
Citation: B. Matthey et al., A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins, GENE, 229(1-2), 1999, pp. 145-153
Authors:
Klimka, A
Barth, S
Matthey, B
Roovers, RC
Lemke, H
Hansen, H
Arends, JW
Diehl, V
Hoogenboom, HR
Engert, A
Citation: A. Klimka et al., An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFV)-ETA ') is a potent immunotoxin against a Hodgkin-derived cell line, BR J CANC, 80(8), 1999, pp. 1214-1222
Risultati:
1-11
|